Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience

Published:2022-06-22 Issue:24 Volume:11 Page:4954-4965
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Slostad Jessica A.¹^ORCID,Yun Nicole K.²^ORCID,Schad Aimee E.³,Warrior Surbhi²,Fogg Louis F.⁴,Rao Ruta¹

Affiliation:

1. Division of Hematology‐Oncology Rush University Medical Center Chicago Illinois USA

2. Department of Internal Medicine Rush University Medical Center Chicago Illinois USA

3. Division of Hematology and Medical Oncology St. Louis University St. Louis Missouri USA

4. Department of Community, Systems, and Mental Health Nursing; College of Nursing Rush University Medical Center Chicago Illinois USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4843

Reference38 articles.

1. Cancer statistics, 2020

2. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer

3. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification

4. Identifying breast cancer patients who require a double-check of preoperative core needle biopsy and postoperative surgical specimens to determine the molecular subtype of their tumor

5. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of magnetic resonance imaging features with five molecular subtypes of breast cancer;European Journal of Radiology Open;2024-12

2. Establishment of an efficient pathologic diagnostic platform using core needle biopsy for salivary gland carcinoma;2024-08-09

3. Use of ultrasound imaging Omics in predicting molecular typing and assessing the risk of postoperative recurrence in breast cancer;BMC Women's Health;2024-07-02

4. Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center;The Breast;2024-06

5. Breast cancer with biomarker reversal during the course of treatment: a case report;Journal of Surgical Case Reports;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3